Net Income Summary of Novo Nordisk A/S

Novo Nordisk A/S's latest annual net income in 2023 was 83.68 Billion DKK , up 50.71% from previous year.
Novo Nordisk A/S's latest quarterly net income in 2024 Q2 was 20.05 Billion DKK , down -21.08% from previous quarter.
Novo Nordisk A/S reported an annual net income of 55.52 Billion DKK in 2022, up 16.27% from previous year.
Novo Nordisk A/S reported an annual net income of 47.75 Billion DKK in 2021, up 13.33% from previous year.
Novo Nordisk A/S reported a quarterly net income of 25.4 Billion DKK for 2024 Q1, up 15.68% from previous quarter.
Novo Nordisk A/S reported a quarterly net income of 19.42 Billion DKK for 2023 Q2, down -1.95% from previous quarter.

Annual Net Income Chart of Novo Nordisk A/S (2023 - 1989)

Historical Annual Net Income of Novo Nordisk A/S (2023 - 1989)

Year	Net Income	Net Income Growth
2023	83.68 Billion DKK	50.71%
2022	55.52 Billion DKK	16.27%
2021	47.75 Billion DKK	13.33%
2020	42.13 Billion DKK	8.18%
2019	38.95 Billion DKK	0.84%
2018	38.62 Billion DKK	1.31%
2017	38.13 Billion DKK	0.54%
2016	37.92 Billion DKK	8.79%
2015	34.86 Billion DKK	31.64%
2014	26.48 Billion DKK	5.15%
2013	25.18 Billion DKK	17.51%
2012	21.43 Billion DKK	25.36%
2011	17.09 Billion DKK	18.7%
2010	14.4 Billion DKK	33.76%
2009	10.76 Billion DKK	11.4%
2008	9.66 Billion DKK	13.25%
2007	8.53 Billion DKK	32.27%
2006	6.45 Billion DKK	10.19%
2005	5.85 Billion DKK	16.0%
2004	5.04 Billion DKK	3.63%
2003	4.87 Billion DKK	19.1%
2002	4.09 Billion DKK	6.22%
2001	3.85 Billion DKK	24.71%
2000	3.08 Billion DKK	28.13%
1999	2.41 Billion DKK	0.06%
1998	2.4 Billion DKK	8.55%
1997	2.21 Billion DKK	23.11%
1996	1.8 Billion DKK	15.42%
1995	1.56 Billion DKK	9.1%
1994	1.43 Billion DKK	0.08%
1993	1.43 Billion DKK	12.39%
1992	1.27 Billion DKK	36.82%
1991	930.19 Million DKK	22.37%
1990	760.12 Million DKK	1.89%
1989	745.98 Million DKK	16.94%

Year	Net Income	Net Income Growth
2024 Q2	20.05 Billion DKK	-21.08%
2024 Q1	25.4 Billion DKK	15.68%
2023 Q2	19.42 Billion DKK	-1.95%
2023 Q1	19.81 Billion DKK	45.78%
2023 FY	83.68 Billion DKK	50.71%
2023 Q4	21.96 Billion DKK	-2.29%
2023 Q3	22.47 Billion DKK	15.7%
2022 Q1	14.21 Billion DKK	30.46%
2022 Q4	13.59 Billion DKK	-5.64%
2022 FY	55.52 Billion DKK	16.27%
2022 Q2	13.31 Billion DKK	-6.28%
2022 Q3	14.4 Billion DKK	8.16%
2021 FY	47.75 Billion DKK	13.33%
2021 Q2	12.12 Billion DKK	-3.96%
2021 Q4	10.89 Billion DKK	-10.12%
2021 Q1	12.62 Billion DKK	35.47%
2021 Q3	12.11 Billion DKK	-0.03%
2020 Q1	11.89 Billion DKK	36.48%
2020 FY	42.13 Billion DKK	8.18%
2020 Q4	9.31 Billion DKK	-9.52%
2020 Q3	10.29 Billion DKK	-3.08%
2020 Q2	10.62 Billion DKK	-10.69%
2019 Q3	10.19 Billion DKK	6.24%
2019 Q1	10.44 Billion DKK	22.93%
2019 Q2	9.59 Billion DKK	-8.14%
2019 FY	38.95 Billion DKK	0.84%
2019 Q4	8.71 Billion DKK	-14.49%
2018 Q1	10.75 Billion DKK	30.27%
2018 Q2	10.34 Billion DKK	-3.79%
2018 Q3	9.03 Billion DKK	-12.63%
2018 FY	38.62 Billion DKK	1.31%
2018 Q4	8.49 Billion DKK	-5.98%
2017 Q2	9.95 Billion DKK	-2.02%
2017 FY	38.13 Billion DKK	0.54%
2017 Q4	8.25 Billion DKK	-15.53%
2017 Q1	10.15 Billion DKK	16.75%
2017 Q3	9.77 Billion DKK	-1.82%
2016 Q4	8.69 Billion DKK	-11.26%
2016 FY	37.92 Billion DKK	8.79%
2016 Q2	9.96 Billion DKK	5.43%
2016 Q3	9.8 Billion DKK	-1.66%
2016 Q1	9.45 Billion DKK	14.5%
2015 FY	34.86 Billion DKK	31.64%
2015 Q1	9.87 Billion DKK	51.26%
2015 Q2	8.34 Billion DKK	-15.52%
2015 Q3	8.38 Billion DKK	0.48%
2015 Q4	8.25 Billion DKK	-1.49%
2014 Q4	6.52 Billion DKK	0.45%
2014 FY	26.48 Billion DKK	5.15%
2014 Q1	6.45 Billion DKK	6.69%
2014 Q3	6.5 Billion DKK	-7.06%
2014 Q2	6.99 Billion DKK	8.3%
2013 Q4	6.05 Billion DKK	-5.64%
2013 FY	25.18 Billion DKK	17.51%
2013 Q3	6.41 Billion DKK	-4.74%
2013 Q2	6.73 Billion DKK	12.57%
2013 Q1	5.98 Billion DKK	3.94%
2012 Q4	5.75 Billion DKK	1.55%
2012 FY	21.43 Billion DKK	25.36%
2012 Q3	5.66 Billion DKK	6.0%
2012 Q2	5.34 Billion DKK	14.62%
2012 Q1	4.66 Billion DKK	-0.53%
2011 Q2	4.13 Billion DKK	1.5%
2011 Q4	4.68 Billion DKK	11.62%
2011 FY	17.09 Billion DKK	18.7%
2011 Q1	4.07 Billion DKK	3.22%
2011 Q3	4.2 Billion DKK	1.62%
2010 FY	14.4 Billion DKK	33.76%
2010 Q4	3.94 Billion DKK	10.07%
2010 Q3	3.58 Billion DKK	1.04%
2010 Q1	3.32 Billion DKK	43.09%
2010 Q2	3.54 Billion DKK	6.74%
2009 FY	10.76 Billion DKK	11.4%
2009 Q3	2.75 Billion DKK	-7.89%
2009 Q2	2.99 Billion DKK	10.82%
2009 Q1	2.69 Billion DKK	14.44%
2009 Q4	2.32 Billion DKK	-15.68%
2008 FY	9.66 Billion DKK	13.25%
2008 Q3	2.66 Billion DKK	7.67%
2008 Q2	2.47 Billion DKK	13.66%
2008 Q1	2.17 Billion DKK	119.17%
2008 Q4	2.35 Billion DKK	-11.46%
2007 Q4	993.1 Million DKK	-54.51%
2007 Q1	1.7 Billion DKK	-0.93%
2007 Q2	3.65 Billion DKK	113.88%
2007 FY	8.53 Billion DKK	32.27%
2007 Q3	2.18 Billion DKK	-40.23%
2006 FY	6.45 Billion DKK	10.19%
2006 Q4	1.72 Billion DKK	-2.96%
2006 Q3	1.77 Billion DKK	1.77%
2006 Q2	1.74 Billion DKK	43.92%
2006 Q1	1.21 Billion DKK	1.77%
2005 Q3	1.74 Billion DKK	4.11%
2005 FY	5.85 Billion DKK	16.0%
2005 Q4	1.19 Billion DKK	-31.88%
2005 Q1	1.22 Billion DKK	-14.6%
2005 Q2	1.68 Billion DKK	36.61%
2004 Q1	1.06 Billion DKK	-21.5%
2004 FY	5.04 Billion DKK	3.63%
2004 Q4	1.44 Billion DKK	15.7%
2004 Q3	1.24 Billion DKK	5.3%
2004 Q2	1.18 Billion DKK	10.54%
2003 Q4	1.36 Billion DKK	20.15%
2003 Q2	1.27 Billion DKK	-73.84%
2003 FY	4.87 Billion DKK	19.1%
2003 Q3	1.13 Billion DKK	-11.32%
2003 Q1	4.88 Billion DKK	319.45%
2002 FY	4.09 Billion DKK	6.22%
2002 Q4	1.16 Billion DKK	16.48%
2002 Q3	1 Billion DKK	18.4%
2002 Q1	963.59 Million DKK	-5.43%
2002 Q2	844.85 Million DKK	-12.32%
2001 Q2	843.16 Million DKK	-17.5%
2001 Q1	1.02 Billion DKK	64.17%
2001 Q4	1.01 Billion DKK	-3.23%
2001 FY	3.85 Billion DKK	24.71%
2001 Q3	1.05 Billion DKK	24.88%
2000 FY	3.08 Billion DKK	28.13%
2000 Q2	931.99 Million DKK	35.93%
2000 Q3	1.74 Billion DKK	87.28%
2000 Q4	622.51 Million DKK	-64.33%
2000 Q1	685.62 Million DKK	3.17%
1999 Q2	634.12 Million DKK	29.59%
1999 Q4	664.56 Million DKK	4.59%
1999 Q3	635.38 Million DKK	0.2%
1999 Q1	489.31 Million DKK	-18.35%
1999 FY	2.41 Billion DKK	0.06%
1998 Q1	584.86 Million DKK	-9.81%
1998 FY	2.4 Billion DKK	8.55%
1998 Q3	603.15 Million DKK	-17.94%
1998 Q4	599.29 Million DKK	-0.64%
1998 Q2	735.01 Million DKK	25.67%
1997 FY	2.21 Billion DKK	23.11%
1997 Q4	648.5 Million DKK	8.56%
1997 Q1	395.92 Million DKK	-14.19%
1997 Q2	551.28 Million DKK	39.24%
1997 Q3	597.37 Million DKK	8.36%
1996 Q3	468.51 Million DKK	1.11%
1996 Q1	398.72 Million DKK	14.07%
1996 FY	1.8 Billion DKK	15.42%
1996 Q2	463.37 Million DKK	16.21%
1996 Q4	461.41 Million DKK	-1.51%
1995 Q4	349.54 Million DKK	-20.88%
1995 FY	1.56 Billion DKK	9.1%
1995 Q3	441.8 Million DKK	-1.33%
1995 Q2	447.74 Million DKK	45.79%
1995 Q1	307.11 Million DKK	-37.95%
1994 Q2	280.57 Million DKK	4.75%
1994 Q4	494.96 Million DKK	29.2%
1994 FY	1.43 Billion DKK	0.08%
1994 Q1	267.84 Million DKK	-36.75%
1994 Q3	383.1 Million DKK	36.54%
1993 FY	1.43 Billion DKK	12.39%
1993 Q4	423.5 Million DKK	3.9%
1993 Q1	289.18 Million DKK	-26.82%
1993 Q2	293.66 Million DKK	1.55%
1993 Q3	407.61 Million DKK	38.8%
1992 FY	1.27 Billion DKK	36.82%
1992 Q4	395.19 Million DKK	73.02%
1992 Q3	228.41 Million DKK	-31.92%
1992 Q2	335.49 Million DKK	3.64%
1992 Q1	323.72 Million DKK	0.0%
1991 Q4	- DKK	0.0%
1991 FY	930.19 Million DKK	22.37%
1991 Q2	- DKK	0.0%
1991 Q1	- DKK	0.0%
1991 Q3	- DKK	0.0%
1990 Q1	- DKK	0.0%
1990 FY	760.12 Million DKK	1.89%
1990 Q4	- DKK	0.0%
1990 Q3	- DKK	0.0%
1990 Q2	- DKK	0.0%
1989 Q3	- DKK	0.0%
1989 Q1	- DKK	0.0%
1989 FY	745.98 Million DKK	16.94%
1989 Q4	- DKK	0.0%
1989 Q2	- DKK	0.0%

Peer Net Income Comparison of Novo Nordisk A/S

Name	Net Income	Net Income Difference
ALK-Abelló A/S	486 Million DKK	-17118.724%
Bavarian Nordic A/S	1.47 Billion DKK	-5572.697%
Genmab A/S	4.35 Billion DKK	-1822.863%
Gubra A/S	-44.52 Million DKK	188050.319%
Orphazyme A/S	-26.04 Million DKK	321364.588%
Pharma Equity Group A/S	-24.6 Million DKK	340150.388%
Zealand Pharma A/S	-703.73 Million DKK	11991.198%

Global Stocks Search

Novo Nordisk A/S (NOVO-B.CO)

Net Income Summary of Novo Nordisk A/S

Annual Net Income Chart of Novo Nordisk A/S (2023 - 1989)

Historical Annual Net Income of Novo Nordisk A/S (2023 - 1989)

Peer Net Income Comparison of Novo Nordisk A/S